TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31

Teladoc Health, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026

$5.73+0.06 (+1.06%)

Close on Oct 19, 2026

Market cap: $1.04B
P/E (TTM): –
Dividend yield: –

Teladoc Health, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31
Revenue	2,530	2,570	2,602	2,407	2,033	1,094	553	418	233	123	77	44	20
Cost of Revenue	772	751	760	744	650	391	184	129	62	32	21	9.93	4.19
Gross Profit	1,758	1,818	1,842	1,663	1,382	703	369	289	172	91	56	34	16
Research & Development	278	307	349	334	312	165	65	54	34	22	14	7.57	3.53
General & Administrative	432	435	465	450	438	507	164	117	80	49	43	18	8.77
Advertising Expenses	546	594	614	504	297	165	89	71	45	30	17	6.00	3.00
Total Costs & Expenses	2,793	3,590	2,851	16,060	2,298	1,600	634	489	309	–	–	–	–
Operating Income	-263	-1,021	-249	-13,653	-266	-506	-80	-71	-75	-63	-56	-15	-5.87
Interest Expense	20	24	22	22	81	–	–	–	–	–	–	–	–
Interest & Investment Income	37	57	47	13	0.78	–	–	–	–	–	–	–	–
Other Non-Operating Income	10	-6.04	4.45	-0.86	5.09	-0.55	0.34	–	–	–	–	–	–
Merger & Restructuring Charges	19	20	17	7.42	0	0	–	1.21	–	–	–	–	–
Asset Impairment Charges	72	790	0	13,403	0	0	0	0	0	0	0	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	0	0	5.50	0	–	–	–	–
Pretax Income	-236	-994	-220	-13,663	-385	-576	-109	-97	-107	-74	-58	-17	-5.93
Income Tax Expense	-35	7.59	0.76	-3.81	44	-91	-11	0.12	-0.23	0.51	0.04	0.39	0.09
Net Income	-200	-1,001	-220	-13,660	-429	-485	-99	-97	-107	-74	-58	-17	-6.02
Preferred Dividends	–	–	–	–	–	–	–	–	–	–	–	2.92	3.62
Net Income to Common	–	–	–	–	–	–	–	–	–	-74	-58	-20	-9.84
EPS (Basic)(per share)	-1.14	-5.87	-1.34	-84.60	-2.73	-5.36	-1.38	-1.47	-1.93	-1.75	-2.91	-10.25	-8.05
EPS (Diluted)(per share)	-1.14	-5.87	-1.34	-84.60	-2.73	-5.36	-1.38	-1.47	-1.93	-1.75	-2.91	-10.25	-8.05
Shares Outstanding (Basic, Weighted)(shares)	176	171	165	161	157	91	72	66	55	42	20	1.96	1.22
Shares Outstanding (Diluted, Weighted)(shares)	176	171	165	161	157	91	72	66	55	42	20	1.96	1.22
EBITDA	–	–	–	-13,397	-61	-437	-41	-35	-56	-54	-51	-13	-5.12
Net Interest Income	–	–	–	-9.27	-80	-60	-29	-26	-17	-2.59	-2.20	-1.50	-0.06

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 69.0%
Operating margin: -7.5%
Net margin: -7.1%
Return on equity, FY2025: -13.9%

Financial strength

Current ratio: 0.83
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 56.0%

Valuation

P/E ratio: –
Price to sales: 0.42
Price to book: 0.79
Dividend yield: –